Cardio Diagnostics Holdings, Inc. is projected to decline to $1.60 by 2027, a -3% move from its current price of $1.64. CDIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.59 | $1.64 | $1.70 | +0.02% |
| Aug 6 | $1.56 | $1.64 | $1.72 | +0.04% |
| Aug 7 | $1.55 | $1.64 | $1.74 | +0.06% |
| Aug 8 | $1.54 | $1.64 | $1.75 | +0.08% |
| Aug 9 | $1.52 | $1.64 | $1.77 | +0.11% |
| Aug 10 | $1.51 | $1.64 | $1.78 | +0.13% |
| Aug 11 | $1.50 | $1.64 | $1.79 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.50 | $1.64 | $1.79 | +0.15% |
| Week 2 | $1.45 | $1.64 | $1.86 | +0.30% |
| Week 3 | $1.41 | $1.65 | $1.92 | +0.44% |
| Week 4 | $1.38 | $1.65 | $1.97 | +0.59% |
| Week 5 | $1.36 | $1.65 | $2.01 | +0.74% |
| Week 6 | $1.33 | $1.65 | $2.05 | +0.89% |
| Week 7 | $1.31 | $1.66 | $2.09 | +1.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cardio Diagnostics Holdings, Inc. is a healthcare company focused on epigenetics-based clinical tests for cardiovascular disease. Its products include Epi+Gen CHD, a three-year symptomatic CHD risk assessment clinical blood test targeting CHD events such as heart attacks, and PrecisionCHD, an integrated epigenetic-genetic test for detecting coronary heart disease.
The company also offers Actionable Clinical Intelligence, a platform providing epigenetic and genetic insights to clinicians for chronic care management, along with CardioInnovate360 for research-use purposes and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. Cardio Diagnostics was founded in 2017 and is headquartered in Chicago, Illinois.
CDIO trades as a healthcare stock and is currently priced at $1.55 per share with a market cap of $4.59M. It holds a rank of 5074 in market capitalization terms. The current price and market position place it among smaller-cap healthcare equities.
A major floor 31.7% below — a decisive break under it would weaken the trend.
The nearest floor, 5.5% below — buyers have tended to step in here.
The nearest ceiling, 34.1% above — a clean break opens room to run.
A major ceiling 47.6% above — clearing it would confirm fresh momentum.
Key CDIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.58 | Buy | $1.58 | Buy |
| MA 10 | $1.60 | Buy | $1.62 | Buy |
| MA 20 | $1.72 | Sell | $1.70 | Sell |
| MA 50 | $1.86 | Sell | $1.84 | Sell |
| MA 100 | $1.98 | Sell | $2.07 | Sell |
| MA 200 | $2.54 | Sell | $3.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.58 | Neutral |
| Stoch RSI (14) | 41.98 | Neutral |
| CCI (20) | -91.25 | Neutral |
| Williams %R (14) | -96.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -12.85 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 4.00 | Buy |
| TRIX (15) | -0.68 | Sell |
| Awesome (5,34) | -0.27 | Sell |
| Ultimate (7,14,28) | 31.18 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 1.55 | Buy |
| ADX (14) | 21.83 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bearish. The RSI14 is 40, signaling modest downside pressure. The stock’s short-moving average sits at $1.87 (SMA50) while the longer-term SMA200 sits at $2.63, suggesting recent weakness relative to longer-term trends. Support is observed at $1.63 and resistance at $2.20, with a 30-day price corridor between $1.24 and $1.93.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.05 | $1.64 | $2.27 | 0% | Neutral | |
| $1.25 | $1.60 | $2.18 | -3% | Neutral | |
| $1.44 | $1.91 | $2.72 | +16% | Neutral | |
| $1.67 | $2.28 | $3.36 | +39% | Bullish | |
| $1.52 | $2.14 | $3.24 | +30% | Bullish | |
| $1.53 | $2.19 | $3.41 | +34% | Bullish | |
| $1.40 | $2.06 | $3.27 | +25% | Bullish | |
| $1.30 | $1.96 | $3.17 | +19% | Neutral | |
| $1.67 | $2.56 | $4.23 | +56% | Bullish | |
| $1.81 | $2.82 | $4.74 | +72% | Bullish | |
| $1.83 | $3.12 | $5.64 | +90% | Bullish | |
| $2.87 | $5.71 | $11.44 | +248% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.05 | $1.64 | $2.05 | +0.00% |
| September 2026 | $1.42 | $1.68 | $2.07 | +2.73% |
| October 2026 | $1.39 | $1.67 | $2.08 | -0.76% |
| November 2026 | $1.45 | $1.75 | $2.21 | +4.93% |
| December 2026 | $1.47 | $1.79 | $2.27 | +2.04% |
Click any year to see its month-by-month CDIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cardio Diagnostics Holdings, Inc.'s 2026 outlook centres on $1.64, within a $1.05 to $2.27 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CDIO could reach as high as $2.18, with a base case around $1.60 and support toward $1.25 — roughly -3% from $1.64. A consolidation phase looks the most probable path here.
Expect CDIO to range from $1.44 to $2.72 through 2028. The $1.91 average target implies a +16% move from current prices. That is up +20% on the projected 2027 average. Price action looks broadly range-bound.
The CDIO price prediction for 2029 points to an average of $2.28 (low $1.67, high $3.36) — a potential gain of +39% on today's $1.64. Buyers look set to stay in control over this stretch.
In 2030, CDIO is projected to trade between $1.52 and $3.24, averaging $2.14 — a potential gain of +30% from today's $1.64. That is -6% versus the projected 2029 average. Momentum favours further upside here.
Cardio Diagnostics Holdings, Inc.'s 2031 outlook centres on $2.19, within a $1.53 to $3.41 range. That is up +3% on the projected 2030 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CDIO could reach as high as $3.27, with a base case around $2.06 and support toward $1.40 — roughly +25% from $1.64. Momentum favours further upside here.
Expect CDIO to range from $1.30 to $3.17 through 2033. The $1.96 average target implies a +19% move from current prices. That is -5% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The CDIO price prediction for 2034 points to an average of $2.56 (low $1.67, high $4.23) — a potential gain of +56% on today's $1.64. Momentum favours further upside here.
In 2035, CDIO is projected to trade between $1.81 and $4.74, averaging $2.82 — a potential gain of +72% from today's $1.64. That is up +10% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cardio Diagnostics Holdings, Inc.'s 2040 outlook centres on $3.12, within a $1.83 to $5.64 range. That is up +11% on the projected 2035 average. That marks a +90% change versus current levels. Momentum favours further upside here.
By 2050, CDIO could reach as high as $11.44, with a base case around $5.71 and support toward $2.87 — roughly +248% from $1.64. Buyers look set to stay in control over this stretch.
Investing $1,000 in CDIO today (≈ 609.756098 CDIO) could be worth
$3,484.57
+$2,484.57 (+248%) by 2050 · US Dollar
Based on the average projected CDIO price of $5.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDIOwould be worth at today's price.
$1,000 invested in CDIO on Jul 31, 2025 (≈ 241.545902 CDIO) would be worth
$396.14
-$603.86 (-60.4%) today · 0.40× · US Dollar
Based on a CDIO entry price of $4.14 vs. today's $1.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.55 | $1,058.06 | +5.8% |
| 1 month ago | $2.11 | $777.25 | -22.3% |
| 3 months ago | $1.88 | $872.34 | -12.8% |
| 6 months ago | $1.45 | $1,131.03 | +13.1% |
| 1 year ago | $4.14 | $396.14 | -60.4% |
| All time (4.5y) ago | $294.6 | $5.57 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDIO forecast.
Our base-case forecast reaches $3.30 around 2050.
Implied market cap at $3.30: $9.77M
The multi-year forecast shows a move into bullish territory in the later years. The 2029 average is $2.06 with a bullish sentiment that year, rising into 2030 with an average of $1.94 and a bullish outlook, and continuing to grow toward 2050 where the average is projected at $4.90 with a bullish sentiment and a max of $9.81. By 2040 the average is $2.73, yielding a 75.9% ROI, and by 2050 the implied ROI reaches 216.4%.
The forecast also lists smaller, neutral years earlier in the cycle (e.g., 2026 average $1.55 with neutral sentiment and 2027 average $1.46 with neutral sentiment). These figures illustrate potential upside over the long run, alongside periods of modest or negative near-term returns.
Tap a question to reveal the answer.
2030: min $1.39, avg $1.94, max $2.95; roiPct 25.3; sentiment BULLISH.
Long-term outlook shows bullish potential, with 2050 avg $4.90 and ROI 216.4%, though near-term years (e.g., 2026-2027) show neutral sentiment or modest declines.
Yes. The forecast includes years with max values above $3: 2029 max $3.05, 2031 max $3.11, 2034 max $3.74, 2035 max $4.13, 2040 max $4.92, and 2050 max $9.81.
Current price is $1.55 and market cap is $4.59M.
Bearish sentiment with RSI14 at 40, SMA50 at $1.87, SMA200 at $2.63, support at $1.63, resistance at $2.20, and a 30-day range from $1.24 to $1.93.
Cardio Diagnostics Holdings, Inc. Community Discussion
0Share your Cardio Diagnostics Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.